Scientists are looking into new ways of preserving a patient’s fertility by ovarian stimulation with different agents, like letrozole, FSH, and tamoxifen, in order to minimize the impact that elevated serum estrogen levels can have on the growth of the tumor. The gene discussed is BRD2; the disease is neoplasm.